Bio-Rad Laboratories

Yahoo Finance • last month

Becton Dickinson, Bio-Rad, and Thermo Fisher Propel Safety and Automation in Blood Collection Tubes—New Market Report Highlights $7Billion Opportunity

Company Logo The blood collection tubes market presents opportunities through innovation in automated systems, advanced materials, and digital traceability to enhance workflow efficiency and compliance. Demand is driven by personalized me... Full story

Yahoo Finance • last month

Bio-Rad, Poly Medicure, and Sekisui Medical Power Rapid Expansion in the Venous Blood Collection Market Through 2032

Company Logo The venous blood collection market is poised for growth, driven by innovations in sampling technology and increasing demand due to chronic disease prevalence. Opportunities lie in automation, user safety, microfluidics, and r... Full story

Yahoo Finance • last month

In Vitro Diagnostic Quality Control Market: Strategy & Trends with Forecasts by Assay Type, by Place, by Product, by Manufacturer and by Country - Situation Analysis with Executive & Consultant Guides

Dublin, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The "In Vitro Diagnostic Quality Control Market: Strategy & Trends with Forecasts by Assay Type, by Place, by Product, by Manufacturer and by Country - Situation Analysis with Executive & Consult... Full story

Yahoo Finance • 2 months ago

Autoimmune Disease Diagnostics Market Competitive Landscape Report 2025: Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts

Company Logo The Autoimmune Disease Diagnostics industry is set for significant growth, projected to leap from US$ 5.70 billion in 2024 to US$ 10.63 billion by 2033, at a CAGR of 7.17%. Key growth drivers include a rising need for precise... Full story

Yahoo Finance • 2 months ago

HbA1c Testing Market Research Report 2025-2033, Profiles of Key Players - Danaher, F. Hoffmann-La Roche, Siemens, Abbott, Bio-Rad Laboratories, ARKRAY, Trinity Biotech, EKF Diagnostics

Company Logo The HbA1c testing market presents opportunities driven by rising Type 2 diabetes cases and advancements in testing technologies. Supportive healthcare initiatives and increased awareness enhance demand. Strategic insights, co... Full story

Yahoo Finance • 3 months ago

Here are the major earnings after the close Wednesday

Major earnings expected after the bell on Wednesday include: * Microsoft Corporation (MSFT [https://seekingalpha.com/symbol/MSFT]) * Alphabet (GOOG [https://seekingalpha.com/symbol/GOOG]) * Meta Platforms (META [https://seekingalpha... Full story

Yahoo Finance • 3 months ago

Bio-Rad (BIO) Surged as the Earnings Exceeded Expectations

Longleaf Partners, managed by Southeastern Asset Management, released its “Partners Fund” third-quarter 2025 investor letter. The letter can be downloaded here. The fund returned -0.33% in the third quarter, compared to the S&P 500’s 8.12... Full story

Yahoo Finance • 3 months ago

Ariel Focus Fund buys AJG, PBH and FI; exits ZIMV, CLB and BIO

* Ariel Focus Fund outperformed the Russell 1000 Value Index and S&P 500 Index by registering a growth of 20.76% in Q3 2025. While the Russell 1000 Value Index posted a gain of 5.33%, the S&P 500 Index registered a return of 8.12%. * I... Full story

Yahoo Finance • 3 months ago

Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital™ PCR High Complexity Assays

Biodesix, Inc. Biodesix will perform the clinical validation of ddPLEX ESR1 Mutation Detection Assay for advanced breast cancer testing LOUISVILLE, Colo., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NYSE: BDSX), a leading diagnosti... Full story

Yahoo Finance • 3 months ago

GCC Liquid Biopsy Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Bio-Rad, Thermo Fisher Scientific, Johnson & Johnson, Guardant Health, QIAGEN, Sysmex

Company Logo The GCC Liquid Biopsy Market is projected to grow from US$ 98.24 million in 2024 to US$ 309.53 million by 2033, at a CAGR of 13.60%. This rapid growth is driven by rising cancer incidence, advances in genomics technology, inc... Full story

Yahoo Finance • 4 months ago

Bio-Rad Laboratories, Inc. (BIO) Launches New Instruments, Boosts Molecular Testing Reach

In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025. Bio-Rad Laboratories, Inc. stands amongst them. Bio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinic... Full story

Yahoo Finance • 4 months ago

Alger Russell Innovation Index Updates for Third Quarter 2025

NEW YORK, Sept. 15, 2025 /PRNewswire/ -- Fred Alger Management, LLC ("Alger"), a privately held growth equity investment manager, today announced the quarterly rebalancing of the Alger Russell Innovation Index ("Index"). Following the clos... Full story

Yahoo Finance • 4 months ago

Is Bio-Rad Laboratories (BIO) Entering a Period of More Sustained Recovery?

Prosper Stars & Stripes, a long/short equity fund, recently released its second quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund underperformed and generated a net return of +9.6% compared to a total retu... Full story

Yahoo Finance • 5 months ago

[Latest] Global Biologics and Biosimilars Market Size/Share Worth USD 1,320.19 Billion by 2034 at a 10.42% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Biologics and Biosimilars Market size & share revenue was valued at approximately US... Full story

Yahoo Finance • 5 months ago

Saudi Arabia Food Safety Testing Market to Surpass Valuation of US$ 598.44 Million by 2033 | Astute Analytica

Chicago, Aug. 19, 2025 (GLOBE NEWSWIRE) -- The Saudi Arabia food safety testing market was valued at US$ 347.13 million in 2024 and is expected to reach US$ 598.44 million by 2033, growing at a CAGR of 6.24% during the forecast period 20... Full story

Yahoo Finance • 5 months ago

Postbiotics Market Set to Surge: New Frontiers in Functional Foods and Skincare

Delray Beach, FL, Aug. 19, 2025 (GLOBE NEWSWIRE) -- According to research report published by MarketsandMarkets, The globalpostbiotics market is on an impressive upward trajectory, projected to increase from USD 146.7 million in 2025 to... Full story

Yahoo Finance • 5 months ago

HTX Hot Listings Weekly Recap (Aug 4-11): DONKEY Up 197% as Meme Coin and Ethereum Ecosystem Tokens Rally

PANAMA CITY, Aug. 18, 2025 (GLOBE NEWSWIRE) -- HTX, a leading global crypto exchange, saw several newly listed assets deliver outsized gains over the past week (Aug 4–11), accompanied by a sharp surge in trading activity. The broader cry... Full story

Yahoo Finance • 5 months ago

Mexico Microcarrier Market Trends and Company Analysis Report 2025-2033 Featuring BD, Thermo Fisher Scientific, Merck, Eppendorf, Danaher, Sartorius, Bio Rad, Corning, Lonza Group, Getinge

Company Logo The Mexico Microcarrier Market is poised for significant growth, projected to reach US$ 77.65 million by 2033 from US$ 39.96 million in 2024, achieving a CAGR of 7.66% from 2025 to 2033. Key drivers include increased investme... Full story

Yahoo Finance • 5 months ago

Renal Transplant Therapeutics Market Insights, Competitive Landscape, and Forecast Report 2024-2032 | Calcineurin Inhibitors Dominate Renal Transplant Therapeutics Market

Company Logo The global renal transplant therapeutics market, valued at USD 11.35 billion in 2024, is projected to grow at a CAGR of 6.29% till 2032, reaching USD 18.39 billion. Factors driving growth include the rising number of kidney t... Full story

Yahoo Finance • 5 months ago

Bio-Rad Laboratories, Inc. (NYSE:BIO) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?

Bio-Rad Laboratories' (NYSE:BIO) stock is up by a considerable 20% over the past three months. However, we decided to pay attention to the company's fundamentals which don't appear to give a clear sign about the company's financial health.... Full story